360 High-Risk Vulnerability Immunization Tool V2.0 vs Oligo Runtime Vulnerability Mgmt: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

Oligo Runtime Vulnerability Mgmt

Mid-market and enterprise teams drowning in open-source vulnerability noise will cut alert fatigue in half with Oligo Runtime Vulnerability Mgmt, which filters CVEs down to what's actually exploitable in production rather than flagging every dependency with a published score. The tool maps full call stacks to confirm exploitability, then automates policy triggers and ticket creation, which means your team stops chasing phantom risks. Skip this if you need supply chain risk management across commercial software or third-party code; Oligo's strength is ruthlessly narrowing scope to runtime open-source threats, leaving upstream SBOM and VEX reporting as secondary features rather than the core narrative.